Blood Hospital
Blood Hospital
Tianjin, Tianjin Municipality, China2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intermediate-dose HAD Regimen for CEBPA Double-mutated AML | acute myeloid leukemia | Recruiting | Not applicable | 2026-08-10 | NCT06529250 | |
| Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Not applicable | 2025-08-03 | NCT06386302 |